By continuing use this site, you agree to the Terms & Conditions and our use of cookies.

Over $10 million investment in PMTA Applications, YOUME Group are fully upgraded

YOUME Group officially engaged in the PMTA application on November 2019, through the unremitting efforts of the local and American PMTA special teams, YOUME successfully completed the required testing content after 8 months, which includes the hazardous substance testing, toxicological analysis, extraction testing, and clinical testing. According to the data drawn by the laboratory, the performance indicators of Suorin products are excellent in terms of design, production, chemical testing, and biological testing.

YOUME GROUP has invested considerable human and material resources in PMTA Application, Product Performance Research, Production Quality Control, etc.  Its elite team is made up by  pathologists, clinical research experts, professional researchers, legal consultants, etc., and the total investment is expected to exceed $10 million. From R&D to Quality Management and Manufacture, YOUME GROUP has upgraded to the high standard of tobacco, medical equipment and the pharmaceuticals by exceeding the standard requirement of PMTA.